SWKH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 18:25):

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development...

Stats
Šios dienos apimtis	1 387.00
Vidutinė apimtis	10 474.00
Rinkos kapitalizacija	215.65M
EPS	$0.230 ( 2024-03-20 )
Kita pelno data	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	13.80
ATR14	$0.0550 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Dotter Laurie L.	Buy	815	Common Stock
2024-04-01	Albright Jerry	Buy	815	Common Stock
2024-04-01	Hatcher Robert K.	Buy	815	Common Stock
2024-04-01	Pennington Marcus Edward	Buy	815	Common Stock
2024-04-01	Pennington Marcus Edward	Buy	1 051	Common Stock

INSIDER POWER
-0.88
Last 96 transactions
Buy: 331 841 \| Sell: 586 098

SWK Holdings Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
MMAC	0.897
NETE	0.869
AMRB	0.854
BOCH	0.838

10 Labiausiai neigiamai susiję koreliacijos
FEYE	-0.906
RMRM	-0.905
APOP	-0.88
SVAC	-0.875
TLGT	-0.869
SVOK	-0.865
PAIC	-0.863
SPRT	-0.825

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

SWK Holdings Corp Finansinės ataskaitos

Annual	2023
Pajamos:	$37.76M
Bruto pelnas:	$34.32M (90.90 %)
EPS:	$1.260

FY	2023
Pajamos:	$37.76M
Bruto pelnas:	$34.32M (90.90 %)
EPS:	$1.260

FY	2022
Pajamos:	$41.48M
Bruto pelnas:	$34.53M (83.24 %)
EPS:	$1.050

FY	2021
Pajamos:	$56.16M
Bruto pelnas:	$48.81M (86.92 %)
EPS:	$2.03

Financial Reports:

No articles found.

SWK Holdings Corp

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.